Katie Tarashuck, Vice President of Finance at Tune Therapeutics, attended as a partner representative. Novotech and Tune Therapeutics’ partnership focuses on a groundbreaking clinical trial ...

Novotech and Tune Therapeutics’ partnership focuses on a groundbreaking clinical trial program advancing an epigenetic therapy with the potential to revolutionize the treatment landscape for ...

Katie Tarashuck, Vice President of Finance at Tune Therapeutics, attended as a partner representative. Novotech and Tune Therapeutics’ partnership focuses on a groundbreaking clinical trial program ...

is proud to announce it has been awarded the Citeline CRO Partnership of the Year Award in recognition of its collaboration with Tune Therapeutics, a pioneering epigenetic editing company.

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including United Therapeutics (NASDAQ:UTHR) and its peers. Over the next ...